|

Hamburg AoRtic Valve cOhoRt

RECRUITINGSponsored by Universitätsklinikum Hamburg-Eppendorf
Actively Recruiting
SponsorUniversitätsklinikum Hamburg-Eppendorf
Started2019-09-01
Est. completion2039-09-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04227002

Summary

The primary aim of the study is to identify the optimal treatment modality for patients with aortic valve disease, incorporating the individual patient's risk profile and anticipated clinical outcomes. This includes the association of demographic factors, procedural data and biomarkers with clinical outcome in a prospective fashion.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients with clinically relevant aortic valve disease (aortic valve stenosis, aortic regurgitation, degenerated aortic valve prosthesis)
* Written informed consent

Exclusion Criteria:

* Insufficient knowledge of the German language (able to understand and write the German language)
* Physical or psychological incapability to take part in the investigation

Conditions2

Aortic Valve StenosisHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.